A detailed history of Swiss National Bank transactions in Rx Sight, Inc. stock. As of the latest transaction made, Swiss National Bank holds 64,600 shares of RXST stock, worth $2.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,600
Previous 54,600 18.32%
Holding current value
$2.17 Million
Previous $3.29 Million 2.8%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$40.78 - $57.04 $407,800 - $570,400
10,000 Added 18.32%
64,600 $3.19 Million
Q2 2024

Aug 08, 2024

BUY
$50.42 - $64.29 $75,630 - $96,435
1,500 Added 2.82%
54,600 $3.29 Million
Q1 2024

May 07, 2024

BUY
$35.51 - $57.92 $262,774 - $428,608
7,400 Added 16.19%
53,100 $2.74 Million
Q4 2023

Feb 06, 2024

BUY
$20.91 - $40.9 $27,183 - $53,170
1,300 Added 2.93%
45,700 $1.84 Million
Q2 2023

Aug 09, 2023

BUY
$16.37 - $28.9 $726,828 - $1.28 Million
44,400 New
44,400 $1.28 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $929M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.